Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
23.57
-0.02 (-0.08%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $51.76 million as of August 20, 2026. Its market cap has increased by 752.96% in one year.
Market Cap
51.76M
Enterprise Value
49.13M
1-Year Change
752.96%
Ranking
Category
Stock Price
$23.57
ChartMarket Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $51.76M, a decrease of -60.06%. That is a compound annual growth rate of -17.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 51.76M | 29.01% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 54.49M |
| Edesa Biotech | 54.43M |
| RenovoRx | 54.16M |
| BioStem Technologies | 53.55M |
| Alps Group | 53.28M |
| TScan Therapeutics | 53.11M |
| Impact BioMedical | 51.47M |
| aTyr Pharma | 50.90M |